Poorer outcome in stromal HIF-2α- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis

por Cleven, A H G, Wouters, B G, Schutte, B, Spiertz, A J G, van Engeland, M, de Bruïne, A P
Publicado 2008

Long-term dietary sodium, potassium and fluid intake; exploring potential novel risk factors for renal cell cancer in the Netherlands Cohort Study on diet and cancer

por Deckers, I A G, van den Brandt, P A, van Engeland, M, Soetekouw, P M M B, Baldewijns, M M L L, Goldbohm, R A, Schouten, L J
Publicado 2014

Molecular profiling of longitudinally observed small colorectal polyps: A cohort study

por van Lanschot, M.C.J., Carvalho, B., Rausch, C., Snaebjornsson, P., van Engeland, M., Kuipers, E.J., Stoker, J., Tutein Nolthenius, C.J., Dekker, E., Meijer, G.A.
Publicado 2018

Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype

por Van der Auwera, I, Van Laere, S J, Van den Bosch, S M, Van den Eynden, G G, Trinh, B X, van Dam, P A, Colpaert, C G, van Engeland, M, Van Marck, E A, Vermeulen, P B, Dirix, L Y
Publicado 2008

Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers

por Joosten, S. C., Odeh, S. N. O., Koch, A., Buekers, N., Aarts, M. J. B., Baldewijns, M. M. L. L., Van Neste, L., van Kuijk, S., Schouten, L. J., van den Brandt, P. A., Tjan-Heijnen, V. C., van Engeland, M., Smits, K. M.
Publicado 2021

Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population

por Bosch, L.J.W., Melotte, V., Mongera, S., Daenen, K.L.J., Coupé, V.M.H., van Turenhout, S.T., Stoop, E.M., de Wijkerslooth, T.R., Mulder, C.J.J., Rausch, C., Kuipers, E.J., Dekker, E., Domanico, M.J., Lidgard, G.P., Berger, B.M., van Engeland, M., Carvalho, B., Meijer, G.A.
Publicado 2019